Skip to main content

GENETIC BASIS OF AUTOIMMUNE DISEASES

JDC2022-048561-I

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Desarrollar, Atraer y Retener Talento
Subprogram Subprograma Estatal de Formación
Call Juan de la Cierva
Call year 2022
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A genetic variant in the 3'-UTR of PIWIL4 confers risk for extreme phenotypes of male infertility by altering miR-215 and miR-136 binding affinity

  • González-Muñoz, Sara
  • Cerván-Martín, Miriam
  • Guzmán-Jimenez, Andrea
  • Rodríguez-Martín, Ana Isabel
  • Garrido, Nicolás
  • Castilla, José A.
  • Gonzalvo, María Carmen
  • Clavero, Ana
  • Molina, Marta
  • Vilches, Miguel Ángel
  • Espuch, Andrea
  • Maldonado, Vicente
  • García-Peña, María Luisa
  • Galiano-Gutiérrez, Noelia
  • Santamaría-López, Esther
  • González, Cristina
  • Quintana-Ferraz, Fernando
  • Gómez, Susana
  • Amorós, David
  • Martínez-Granados, Luis
  • Ortega-González, Yanira
  • Burgos, Miguel
  • Pereira-Caetano, Iris
  • Pinto, María Graça
  • Aguiar, Ana
  • Pereira, Isabel
  • López-Rodrigo, Olga
  • Bassas, Lluis
  • Seixas, Susana
  • Gonçalves, João
  • Lopes, Alexandra M.
  • Larriba, Sara
  • Bossini-Castillo, Lara
  • Carmona, Francisco David
  • Palomino-Morales, Rogelio
A correction has been published: Human Reproduction, Volume 40, Issue 9, September 2025, Page 1797, https://doi.org/10.1093/humrep/deaf142, What is the functional impact of the rs508485 genetic polymorphism, located in the 3'-untranslated region (UTR) region of the PIWIL4 gene, on non-obstructive azoospermia (NOA)?, This work was supported by the Spanish Ministry of Economy and Competitiveness through the Spanish National Plan for Scientific and Technical Research and Innovation (grant: PID2020-120157RB-I00 funded by MICIU/AEI/10.13039/501100011033; and grant: PID2023-152215OB-I00 funded by MICIU/AEI/10.13039/501100011033 and ERDF, EU). M.C.-M is beneficiary of a Juan de la Cierva 2022 postdoctoral fellowship (reference number JDC2022-048561-I) funded by MCIN/AEI/10.13039/501100011033 and European Union NextGenerationEU/PRTR. S.L. received support from “Generalitat de Catalunya” (grant 2021SGR052). S.L. is sponsored by the “Researchers Consolidation Program” from the SNS-Dpt. Salut Generalitat de Catalunya (Exp. CES09/020). S.G.-M. was funded by grant ref. FPU23/02674. S.S. was supported by funds from the Portuguese Foundation for Science and Technology (FCT; 10.54499/DL57/2016/CP1363/CT0019)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Unraveling the molecular landscape of Erdheim-Chester disease: new insights from methylome and transcriptome integration

  • Cerván-Martín, Miriam
  • Pegoraro, Francesco
  • Martínez-López, Javier
  • Rodríguez-Martín, Inmaculada
  • Márquez, Ana
  • Ortiz-Fernández, Lourdes
  • Acosta-Herrera, Marialbert
  • Kerick, Martin
  • Andrés-León, Eduardo
  • Catamerò, Francesco
  • Papo, Matthias
  • Cohen-Aubart, Fleur
  • Amoura, Zahir
  • Haroche, Julien
  • Vaglio, Augusto
  • Martín, Javier
Erdheim-Chester Disease (ECD) is a rare histiocytosis characterized by a wide spectrum of clinical manifestations. Although somatic mutations have been involved in ECD, its etiology remains poorly understood. This study aimed to identify novel molecular mechanisms involved in ECD through the first integrated methylome and transcriptome analysis. Peripheral blood samples were collected from 137 ECD patients and 410 controls. Genome-wide DNA methylation and transcriptome analyses were performed, followed by functional in silico studies using different online bioinformatics tools. Subsequently, methylome and transcriptome data were integrated, and a drug repurposing approach was undertaken. Our results revealed 2511 differentially methylated positions and 1484 differentially expressed genes associated with ECD. The integrative analysis identified 46 alterations in DNA methylation patterns that regulate the expression levels of 29 altered genes in ECD patients, highlighting key genes involved in immune response and tumorigenesis. Remarkably, our results identified B cells and NF-kB signaling pathway as novel contributors of ECD pathogenesis. Finally, the drug repurposing analysis identified potential therapeutic options for ECD patients. In conclusion, this study represents an important advance in understanding the molecular basis of ECD, proposing novel cell types and pathways involved in ECD pathogenesis and suggesting new avenues for clinical management., This work was supported by the project “Genome-wide and epigenome-wide association study in patients with Erdheim-Chester Disease,” funded by Histio UK. M.C.-M is beneficiary of a Juan de la Cierva 2022 postdoctoral fellowship (reference number JDC2022-048561-I) funded by MCIN/AEI/ 10.13039/501100011033 and European Union NextGenerationEU/PRTR. J.M.L was supported by a predoctoral contract in health related research (PFIS) (FI23/00231) from ISCIII. I.R.M was supported by the program FPU (FPU21/02746) funded by the Spanish Ministry of Science Innovation and Universities. L.O.F. is recipient of a Ramon y Cajal fellowship [RYC2022-036635-I] funded by MICIU/AEI/10.13039/501100011033 and by ESF+., Peer reviewed